x战警

China's pharmaceutical industry sees accelerated innovation breakthroughs in H1_我的网站

第八号当铺

A | (ECNS) -- China's pharmaceutical industry accelerated innovation in the first half of this year, with domestic companies steadily improving their R&D capabilities and growth momentum continuing to strengthen, data showed. China's first broad-spectrum targeted anticancer drug entered clinical use at major hospitals across the country this year. It took only eight months to go from submission to market approval. A total of 38 innovative drugs were approved for marketing in China in the first half, of which 31 were developed domestically, more than 80% of the total. Eleven drugs featuring new targets or new mechanisms were all developed independently by domestic companies, producing a number of world-first innovations. By the end of 2025, China had 4,751 innovative drugs under development, one-third of the global total and the largest pipeline of any country. Behind this concentration of results lies a steadily strengthening industrial base. China has a complete pharmaceutical supply chain. It is not only the world's largest producer of active pharmaceutical ingredients but has also built a production system covering every pharmaceutical category. This year, digital, intelligent, and green technologies have driven the industry's transformation and upgrading. At a biopharmaceutical company in Shanxi Province, a newly built AI-powered bio-computing center can identify the structures of millions of protein functional domains in a short time, screening out ineffective molecules directly. To date, China has supported 21 pharmaceutical firms in building excellent-level smart factories and has cultivated more than 300 green factories. In the first half, the added value of pharmaceutical enterprises above the designated scale grew 6.4% year on year, and exports held strong. The world's first chemotherapy-sparing drug for gastric cancer, launched this year, had already earned overseas revenue through licensing deals before it reached the market, and is now exported to multiple countries and regions. In the first half, the total value of China's innovative drug out-licensing deals reached $110 billion, the industry's export delivery value grew 9% year on year, and high-value-added products made up nearly 20% of the total. (By Tang Yuxian) 。一场水上情缘体验别样浪漫每日商报讯晚风携雾，星河赴约。8月18日至20日，建德新安江景区推出“星河渡・水上情缘”七夕游船沉浸式NPC主题活动，依托新安江17℃江水与白沙奇雾独特夜景，打造流动的水上古风剧场，为游客带来别样的七夕浪漫体验。本次活动设在风月轩旅游码头，梦幻三号游轮、龙舟、竹筏、快艇多类游船同步开放，面向情侣、闺蜜、汉服爱好者及家庭游客。卖花牛郎、织女、喜鹊仙童、渔家姑娘古风NPC分布码头与航线沿途，游客登船即可入戏，不再是单纯观光，而是沉浸式参与剧情互动。航行途中，牛郎与游客开展诗词飞花令，为单人游客送上祈福心愿卡；织女引导情侣对视告白，完成互动即可领取“万事胜意”纪念杯；喜鹊仙童穿梭船舱甲板，石头剪刀布、派发荧光手环，氛围感拉满。